Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism and Outcome-based Care Models

High adoption of annuity-based reimbursement programs by payers and therapy manufacturers will unlock the potential of gene therapies, finds Frost & Sullivan

SANTA CLARA, Calif., — Despite rising trade tension and a sluggish economic outlook for 2020, the global healthcare industry is set for an invigorating year due to a partial realization of major healthcare policies and initiatives and technology advancements. Moreover, value-based care is driving the adoption and need for consumer-centric targeted therapies. Retail giants such as Amazon, Walmart, CVS, Ali Health, and Best Buy will continue to make further headway into the individual care space, driving the “comparison shopping” consumer trend for healthcare services and products. With these trends, the overall global healthcare market is poised...